Oil and gas producer Empyrean Energy (LON: EME) says the operator of the Mako field has signed a gas sales agreement with PT PLN Energi Primer Indonesia. This covers the current production from the Duyung production sharing contract until January 2027. Empyrean Energy has an 8.5% interest in the Mako field. The share price soared 440% to 0.108p.
Oxford BioDynamics (LON: OBD) says Pfizer has published information on its use of EpiSwitch biomarkers as a liquid biopsy in evaluating tumours and treatment outcomes for the JAVELIN bladder 100 trial. The EpiSwitch test can determine whether a tumour has high or low immune activity. This confirmation of efficacy will help to grow EpiSwitch sales. Trafalgar Capital Management has taken a 3.3% stake. The share price jumped 102% to 0.525p.
Eco Animal Health (LON: EAH) reported a drop in full year revenue from £89.4m to £79.6m, but non-core disposals helped pre-tax profit improve by one-third to £4m. Net cash was £25m at the end of March 2025. North America was the only region where sales increased. Chief executive David Hallas bought 29,987 shares at 66.8953p each. The share price increased 41.2% to 80.5p.
Orosur Mining Inc (LON: OMI) has announced positive early results from mineral resource estimate drilling at the Pepas prospect within the Anza gold project area in Colombia. Grades of up to 12.76g/t have been found. This area may offer near term production opportunities. The share price rose 34% to 10.25p.
FALLERS
Metals One (LON: MET1) is acquiring an initial 10% stake in NovaCore Exploration Inc and it has warrants that can increase the stake to 30%. This adds a third uranium project to the company’s portfolio. NovaCore has 15,000 acres in the Red Basin uranium district in New Mexico. This has potential for 40 million pounds of U3O8. Initial drilling is planned for the end of 2025 if permitting and environmental work is completed on time. Earlier in the week, a sale and purchase agreement was executed for the purchase of Mjolner Minerals, which owns the Lillefjellklumpen platinum group elements project in central Norway. The share price slumped 54% to 11.74p.
Cybersecurity service provider Corero Network Security (LON: CNS) has increased annual recurring revenues by one-quarter to $21.6m because of demand for managed services, but recognised revenues are lower in the first quarter. Canaccord Genuity has cut its 2025 forecast revenues from £28.7m to £24.1m and that would mean the company returning to loss. Software and equipment sales are lower, and visibility of orders is poor. The share price slipped 41% to 9p.
AFC Energy (LON: AFC) raised £23m at 10p/share via a placing and subscription, which was more than initially asked for, and up to £5m can be raised via a retail offer. The cash will fund commercialisation of hydrogen technology, particularly for generator and hydrogen supply. It will fund the manufacture of Hy-5 and 30Kw units for Volex. Interim revenues were £17,000 and the loss was £10.1m. There was cash of £4.27m at the end of April 2025 and the burn rate is being reduced. The share price decreased 34.2% to 10.72p.
Trading in Artemis Resource (LON: ARV) shares has been halted on ASX because it is raising cash to finance the development of its gold assets. AIM trading continues and the share price fell 32.7% to 0.185p.